FIGURE

Table 1

ID

ZDB-FIG-191231-2

Publication

Serafini et al., 2018 - A limb-girdle muscular dystrophy 2I model of muscular dystrophy identifies corrective drug compounds for dystroglycanopathies

Other Figures

All Figure Page

Back to All Figure Page

Table 1

ZFIN is incorporating published figure images and captions as part of an ongoing project. Figures from some publications have not yet been curated, or are not available for display because of copyright restrictions.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Fish:	fkrp^{uab203/uab203}; uab202Tg
Conditions:	chemical treatment: alverine citrate, heat shock chemical treatment: aztreonam, heat shock chemical treatment: betulin, heat shock chemical treatment: calycanthine, heat shock chemical treatment: chlorphenesin carbamate, heat shock chemical treatment: streptomycins, heat shock chemical treatment: flumequine, heat shock chemical treatment: ipratropium bromide, heat shock chemical treatment: Kawain, heat shock chemical treatment: metampicillin sodium, heat shock chemical treatment: metaraminol bitartrate, heat shock chemical treatment: ornidazole, heat shock chemical treatment: oxymetazoline hydrochloride, heat shock chemical treatment: paclitaxel, heat shock chemical treatment: perphenazine, heat shock chemical treatment: pirenzepine hydrochloride, heat shock chemical treatment: rimexolone, heat shock chemical treatment: sulfacetamide sodium, heat shock chemical treatment: Thioproperazine mesilate, heat shock chemical treatment: ursolic acid, heat shock
Observed In:	eye head pericardium skeletal muscle whole organism
Stage:	Day 5

Phenotype Detail

Acknowledgments

Full text @ JCI Insight